BPMC – blueprint medicines corporation (US:NASDAQ)
Stock Stats
News
11/18
01:35 pm
bpmc
Low
Blueprint Medicines Co. (NASDAQ: BPMC) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $125.00 price target on the stock.
11/15
08:04 am
bpmc
Medium
Blueprint Medicines Co. (NASDAQ: BPMC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $135.00 price target on the stock.
11/15
08:04 am
bpmc
Medium
Blueprint Medicines Co. (NASDAQ: BPMC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $135.00 price target on the stock.
11/14
06:29 pm
bpmc
Medium
Blueprint Medicines Co. (NASDAQ: BPMC) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $135.00 price target on the stock.
11/14
10:14 am
bpmc
Low
Recludix Pharma to Present Data Demonstrating its Oral STAT3 Inhibitor has Differentiated Efficacy and Safety as Compared to JAK/TYK2 Inhibition in In Vivo Models of Inflammatory Arthritis [Yahoo! Finance]
10/30/2024
07:00 am
BPMC
5.5%
BEAT
8/1/2024
07:00 am
BPMC
-7.4%
BEAT
5/2/2024
07:00 am
BPMC
7.0%
BEAT
2/15/2024
07:00 am
BPMC
14.0%
BEAT
11/18
01:35 pm
Reiterates
Market Outperform
Market Outperform
JMP Securities
Low
2.4%
11/18
01:35 pm
Reiterates
Market Outperform
Market Outperform
JMP Securities
Low
2.4%
11/18
12:52 pm
Reiterates
Market Outperform
Market Outperform
JMP Securities
Low
1.8%
11/18
12:52 pm
Reiterates
Market Outperform
Market Outperform
JMP Securities
Low
1.8%
11/15
08:04 am
Reiterates
Buy
Buy
Needham & Company LLC
Medium
-7.6%
11/21
04:23 pm
bpmc
Low
Form 144 Blueprint Medicines Corp Filed by: COATS LONNEL
11/20
04:30 pm
bpmc
Low
Form 144 Blueprint Medicines Corp Filed by: COATS LONNEL
11/14
01:24 pm
bpmc
Low
Form SC 13G/A Blueprint Medicines Corp Filed by: PRICE T ROWE ASSOCIATES INC /MD/
11/12
04:16 pm
bpmc
Low
Form 4 Blueprint Medicines Corp For: Nov 07 Filed by: Albers Jeffrey W.
11/12
01:45 pm
bpmc
Low
Form 144/A Blueprint Medicines Corp Filed by: Albers Jeffrey W.
Show more
Top News Gainers
3/16 Blueprint Medicines Corp (NASDAQ: BPMC) was upgraded by analysts at Deutsche Bank AG from a "hold" rating to a "buy" rating. 22.1%
3/24 Blueprint Medicines Corp (NASDAQ: BPMC) had its "outperform" rating re-affirmed by analysts at Wedbush. 11.5%
3/19 Blueprint Medicines Corp (NASDAQ: BPMC) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. 8.1%
5/9 Q1/2019 3/31/2019 EPS -1.980 ZacksConsensus -1.830 ActVsEst (0.150) - Miss 7.2%
6/4 Form 8-K Blueprint Medicines Corp For: Jun 03 6.8%
2/14 Blueprint Medicines (BPMC) Q4 2019 Earnings Call Transcript [The Motley Fool] 6.3%
3/25 Form 4 Blueprint Medicines Corp For: Mar 23 Filed by: Albers Jeffrey W. 6.2%
6/5 Blueprint Medicines Corp (NASDAQ: BPMC) was upgraded by analysts at ValuEngine from a "buy" rating to a "strong-buy" rating. 5.7%
3/3 Form 4 Blueprint Medicines Corp For: Mar 01 Filed by: Dorsch Marion 5.2%
11/5 Form 4 Blueprint Medicines Corp For: Nov 01 Filed by: Rossi Christina 5.1%
Top News Decliners
4/28 Blueprint Medicines Announces Top-line Results from Phase 3 VOYAGER Trial of Avapritinib versus Regorafenib in Patients with Advanced Gastrointestinal Stromal Tumor -17.3%
3/16 Form CT ORDER Blueprint Medicines Corp -13.7%
10/28 Form 8-K Blueprint Medicines Corp For: Oct 25 -13.7%
1/21 Form 424B5 Blueprint Medicines Corp -12.4%
12/6 Form 4 Blueprint Medicines Corp For: Dec 04 Filed by: Hurley Ariel -10.9%
1/13 Form 8-K Blueprint Medicines Corp For: Jan 13 -10.6%
3/11 Form 4 Blueprint Medicines Corp For: Mar 09 Filed by: Rossi Christina -7.2%
3/17 Form SEC STAFF LETTER Blueprint Medicines Corp -6.5%
8/1 Form 8-K Blueprint Medicines Corp For: Aug 01 -6.3%
9/9 Lilly's targeted RET drug shrinks tumors in lung cancer trial [Reuters] -6.1%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3